Lucosky Brookman is a leader in the representation of small and micro-cap companies. The Firm has led it clients through numerous capital raise transaction and over a dozen uplisting and initial public offering transactions. Access the latest news about Lucosky Brookman, our clients’ business transactions and industry updates here.
Lucosky Brookman LLP is proud to announce its role as Special NASDAQ Counsel to U Power Limited ("U Power" or the "Company"), a company focused…
Read More
Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC (“EF Hutton), on its successful $4.0 million…
Read More
Lucosky Brookman LLP is proud to announce its role as Special NASDAQ Counsel to Mangoceuticals, Inc. ("MangoRx" or the "Company"), a company…
Read More
Lucosky Brookman is proud to congratulate their client, SOBR, on their successful partnership with Aegis Capital Corp. As a trusted legal advisor…
Read More
Lucosky Brookman LLP congratulates its client Unique Logistics International, Inc. (NASDAQ: UNQL), a global logistics and freight…
Read More
Lucosky Brookman congratulates its client, Clean Vision Corporation (OTCQB: CLNV) (“Clean Vision” or the “Company”), an emerging leader in…
Read More
Lucosky Brookman LLP is proud to announce its role as Special NASDAQ Counsel to Lucy Scientific Discovery, Inc. in connection with the…
Read More
Sonnet Biotherapeutics, a leading biotechnology company, closed a $15 million underwritten public offering. The offering was underwritten by…
Read More
Lucosky Brookman LLP congratulates its client, Grom Social Enterprises, Inc. (NASDAQ: GROM) (the “Company”), a media, technology and…
Read More
We are thrilled to extend our warmest congratulations to Steven A. Lipstein, who has been promoted to Partner at Lucosky Brookman LLP.…
Read More